Cargando…
Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2(−/−) acute myeloid leukemia
BACKGROUND: Heterogeneity of leukemia‐initiating cells (LICs) is a major obstacle in acute myeloid leukemia (AML) therapy. Accumulated evidence indicates that the coexistence of multiple types of LICs with different pathogenicity in the same individual is a common feature in AML. However, the functi...
Autores principales: | Song, Jiachun, Du, Longting, Liu, Ping, Wang, Fuhui, Zhang, Bo, Xie, Yinyin, Lu, Jing, Jin, Yi, Zhou, Yan, Lv, Gang, Zhang, Jianmin, Chen, Saijuan, Chen, Zhu, Sun, Xiaojian, Zhang, Yuanliang, Huang, Qiuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441059/ https://www.ncbi.nlm.nih.gov/pubmed/34196511 http://dx.doi.org/10.1002/cac2.12189 |
Ejemplares similares
-
Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells
por: Chen, Zhiwei, et al.
Publicado: (2021) -
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
por: Sun, Jiewen, et al.
Publicado: (2020) -
Lysosome-mediated chemoresistance in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2022) -
DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
por: Lebecque, Benjamin, et al.
Publicado: (2021) -
Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
por: Wang, Suwei, et al.
Publicado: (2019)